Apply This IPO

Best Margin

Zero Brokerage

24*7 Customer Support.

Fastest mobile support

---

Apply with Angel One

Apply with Zerodha

Pre-Apply with Upstox

Mono Pharmacare Limited IPO Review

Mono Pharmacare Limited was engaged in promoting pharmaceutical products and serving as distributors for multiple pharmaceutical firms. They collaborate with different contract manufacturers who produce pharmaceutical products according to the formulas they provide. Later, they market and sell these products under their brand "DLS Export." You can rely on us for top-notch pharmaceutical goods. As a prominent name in the pharma sector, they're dedicated to providing you with excellent products and services that cater to your health requirements.

Their Business Process is Finalizing order quantity and composition, estimating the demand for the product, selecting of contract manufacturer, Providing the required composition to the manufacturer, Manufacturer sourcing materials themselves, Product manufactured by the manufacturer, Marketing & distribution through their own network, Checking existing inventory status, Purchase and receipt of goods, Dispatch of order

Mono Pharmacare Limited Products and Services

Their Products are Antibiotic, Anti- Fungal, Anti cough and Cold, Anti Allergic, Antacid and Antiemetics, Analgesic and Antipyretic, Nutraceuticals, Skincare, Cardiac and Diabetic, Antiseptic, Cosmetic, Bronchodilators, Probiotics, Antihistamines. They work directly with pharmaceutical manufacturers to sell their products, serving as a link between them and retail pharmacies, doctors, and healthcare centers to streamline the supply chain.

Mono PharmaCare Limited IPO is a distributor that has a combination of retail pharmacies and wholesale operations. Monopharma pvt ltd founders bring together over ten years of experience in the pharmaceutical field. They have been the driving force behind their company's expansion from the start, and with their valuable expertise and forward-looking mindset, they aspire to keep thriving in the pharmaceutical sector. They give instructions for creating each pharmaceutical product with specific formulas. Once they get the necessary raw materials, their manufacturing partners start making the products as per their directions and orders.

Financial Overview

The company partners with major pharmaceutical firms as a distributor and has shown strong performance during the documented time frames. Considering the financial results for the fiscal year 2023, the problem seems to have a high price set with a bold approach. Well informed, Investors may think of applying for this IPO.